These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36466981)

  • 21. Cytogenetic polyclonality in hematologic malignancies.
    Johansson B; Billström R; Broberg K; Fioretos T; Nilsson PG; Ahlgren T; Malm C; Samuelsson BO; Mitelman F
    Genes Chromosomes Cancer; 1999 Mar; 24(3):222-9. PubMed ID: 10451702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia.
    Crisan AM; Coriu D; Arion C; Colita A; Jardan C
    J Med Life; 2015; 8(4):502-8. PubMed ID: 26664479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.
    Bidet A; Dulucq S; Smol T; Marceau-Renaut A; Morisset S; Coiteux V; Noël-Walter MP; Nicolini FE; Tigaud I; Luquet I; Struski S; Gaillard B; Penther D; Tondeur S; Nadal N; Hermet E; Véronèse L; Réa D; Gervais C; Theisen O; Terré C; Cony-Makhoul P; Lefebvre C; Gaillard JB; Radford I; Vervaeke AL; Barin C; Chapiro E; Nguyen-Khac F; Etienne G; Preudhomme C; Mahon FX; Roche-Lestienne C;
    Haematologica; 2019 Jun; 104(6):1150-1155. PubMed ID: 30573507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.
    Terre C; Eclache V; Rousselot P; Imbert M; Charrin C; Gervais C; Mozziconacci MJ; Maarek O; Mossafa H; Auger N; Dastugue N; Talmant P; Van den Akker J; Leonard C; N'Guyen Khac F; Mugneret F; Viguié F; Lafage-Pochitaloff M; Bastie JN; Roux GL; Nicolini F; Maloisel F; Vey N; Laurent G; Recher C; Vigier M; Yacouben Y; Giraudier S; Vernant JP; Salles B; Roussi J; Castaigne S; Leymarie V; Flandrin G; Lessard M;
    Leukemia; 2004 Aug; 18(8):1340-6. PubMed ID: 15190256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare monosomy 7 and deletion 7p at diagnosis of chronic myeloid leukemia in accelerated phase.
    Alswied A; Rehman A; Lai LW; Duran J; Sardar M; Proytcheva MA
    Cancer Genet; 2021 Apr; 252-253():111-114. PubMed ID: 33497941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary chronic myeloid leukemia following acute myeloid leukemia treated with autologous hematopoietic stem cell transplantation: a case report.
    Cheng J; Liao Y; Bin T; OUYang J; Chen S; Chen X; Zou W
    Curr Med Res Opin; 2020 Nov; 36(11):1807-1812. PubMed ID: 32936052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
    Johansson B; Fioretos T; Mitelman F
    Acta Haematol; 2002; 107(2):76-94. PubMed ID: 11919388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia.
    Kovitz C; Kantarjian H; Garcia-Manero G; Abruzzo LV; Cortes J
    Blood; 2006 Oct; 108(8):2811-3. PubMed ID: 16809614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.
    Larsson N; Billström R; Lilljebjörn H; Lassen C; Richter J; Ekblom M; Fioretos T
    Cancer Genet Cytogenet; 2010 Jun; 199(2):89-95. PubMed ID: 20471511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A significant proportion of patients with chronic myeloid leukemia and suboptimal response according to European Leukemia Net criteria have excellent prognosis without treatment change.
    Rohon P; Faber E; Divoka M; Rozmanova S; Friedecky D; Jarosova M; Indrak K
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Jun; 157(2):181-8. PubMed ID: 22660209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.
    Lin Y; Bruyère H; Horsman DE; Pantzar T; Barnett MJ; Hogge DE; Nevill TJ; Nantel SH; Sutherland HJ; Toze CL; Shepherd JD; Lavoie JC; Song KW; Smith CA; Forrest DL
    Cancer Genet Cytogenet; 2006 Oct; 170(1):16-23. PubMed ID: 16965950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias.
    Maiti A; Franquiz MJ; Ravandi F; Cortes JE; Jabbour EJ; Sasaki K; Marx K; Daver NG; Kadia TM; Konopleva MY; Masarova L; Borthakur G; DiNardo CD; Naqvi K; Pierce S; Kantarjian HM; Short NJ
    Acta Haematol; 2020; 143(6):567-573. PubMed ID: 32289808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities.
    Pawarode A; Sait SN; Nganga A; Coignet LJ; Barcos M; Baer MR
    Leuk Res; 2007 Nov; 31(11):1589-92. PubMed ID: 17391756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
    Tamura S; Kanamaru A; Takemoto Y; Kakishita E; Nagai K
    Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A unique case of complex variant translocation of t(6;9;22)(p22;q34;q11.2), der(19) in a newly diagnosed patient with chronic myeloid leukemia.
    Ciftciler R; Saglam EA; Inanc A; Ozcebe O; Haznedaroglu IC
    Cancer Genet; 2019 Sep; 237():78-81. PubMed ID: 31447069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient treated with hydroxyurea.
    Flamm MJ; Murty VV; Rao PH; Nichols GL
    Leuk Res; 2002 Apr; 26(4):417-20. PubMed ID: 11839390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Viswanathan K; Roboz G; Chadburn A; Mathew S
    Int J Surg Pathol; 2020 Apr; 28(2):216-224. PubMed ID: 31544558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.
    Osman AEG; Deininger MW
    Blood Rev; 2021 Sep; 49():100825. PubMed ID: 33773846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.